# Assessment Challenges in Medical Devices, Pharma & Biotech

> Expanded qualitative synthesis of 17 practitioner discussions: detailed, neutral descriptions of assessment-related challenges described by medical device, pharmaceutical, and biotechnology practitioners, grouped as GAP, RISK and CONTROL.

- Status: Current. Last verified 2026-10-15.
- Applies to: Qualitative synthesis of 17 public practitioner discussions, October 2026. Not facts about AskDona, verified audit findings or prevalence statistics.
- Canonical: https://askdona.com/ai/assessment-challenges-overview.md

Expanded qualitative synthesis of 17 practitioner discussions

## Scope and approach

This expanded report reformulates discussions by medical device, pharmaceutical, and biotechnology practitioners into detailed, neutral descriptions of assessment-related challenges. It removes personal complaints and emotionally charged language while preserving the operational examples, differing perspectives, and uncertainties described in the discussions. Each entry includes a more developed explanation of the assessment problem, its practical implications, and the central issue to resolve.

These are qualitative accounts, not verified audit findings or prevalence statistics. Where practitioners disagree about a regulatory interpretation, their views are presented as perspectives rather than definitive legal requirements. This report should not replace device-specific regulatory or technical assessment.